A Within-Scar, Randomized Control Trial Comparing Fractional Ablative Carbon Dioxide Laser to Non-Energy- Based, Mechanical Tissue Extraction and No Treatment
Abstract
Survivors of burn injuries face many challenges in their recovery. One of those challenges they commonly face is the result of scarring from their injury. These particular scars can be quite debilitating as they can limit mobility of the skin, result in decreased movement to parts of the body, and also be associated with pain and itching. While there are non-surgical treatments for these scars, they can be very expensive, time consuming and uncomfortable for patients and have limited improvements. Surgical treatments for the scarring exist, but they have their own downsides including pain, risk of complications, and longer recovery. The introduction of fractional ablative carbon dioxide lasers has offered tremendous potential to help improve scars with minimal pain, downtime, and cost compared to the traditional approaches. Despite the promising studies we do not have clear data demonstrating whether the laser works, how it works, or more importantly how the impact of laser treatment changes peoples quality of life or long-term outcomes. This study is designed to begin to address these gaps in our current knowledge.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2022
- Accession Number
- AD1201237
Entities
People
- Jonathan Friedstat
Organizations
- Massachusetts General Hospital